[Macrolide resistance and detection in Mycoplasma pneumoniae at Kansai Medical University Hirakata Hospital].

Authors:
Address: Department of Clinical Laboratory, Kansai Medical University Hirakata Hospital.
Journal:


Publication:

abstract

Mycoplasma pneumoniae causes bronchitis and pneumonia predominantly in subjects 5 to 20 years old. M. pneumoniae is detected by measuring specific antibodies and/or isolating the microorganism, but the frequency of false-positive/negative results, and the culture time required until isolation pose problems. We detected M. pneumoniae using real-time PCR with clinical specimens. We also determined the drug sensitivity of isolated M. pneumoniae and searched for the gene mutation responsible for Macrolide resistance. In 275 cases of suspected M. pneumoniae infection, positive cases in real-time PCR numbered 40 (14.5%). Of these, 16 showed positive culture (5.8%). Of these 16, A2063G point mutation that causes macrolide resistance was found in 12. Drug sensitivity testing showed resistance to clarithromycin (MIC> or =64 microg/ml) in 11 and susceptibility in 4 (MIC 0.0039 microg/ml). The clarithromycin resistance ratio was 75%. Growth was insufficient for testing in 1 case. M. pneumoniae was susceptible to minocycline and all quinolone drugs. M. pneumoniae detection using real-time PCR proved much more sensitive than conventional culture. Macrolide resistance results correlated well with genomic mutation. Our study's macrolide resistance ratio was high at 75% possibly due to a restricted subject population that had been administered macrolide drugs elsewhere but with an unsatisfactory outcome. The increasing number of reports on macrolide resistance requires that we monitor drug resistance trends, particularly among macrolide derivatives.



Related Articles
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
Antimicrob Agents Chemother. 2...
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Antimicrob Agents Chemother. 2008 Oct; 52(10):3542-9. Epub 2008 Jul 21.
Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Pediatr Infect Dis J. 2009
Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Pediatr Infect Dis J. 2009 Aug; 28(8):693-6.
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.
J Antimicrob Chemother. 2009
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.
Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, Pereyre S. J Antimicrob Chemother. 2009 Jul; 64(1):52-8. Epub 2009 May 9.
Review Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
J Infect Chemother. 2010
Review Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
Morozumi M, Takahashi T, Ubukata K. J Infect Chemother. 2010 Apr; 16(2):78-86. Epub 2010 Jan 22.
Review Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
Future Microbiol. 2011
Review Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
Bébéar C, Pereyre S, Peuchant O. Future Microbiol. 2011 Apr; 6(4):423-31.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.